Filters
A test-negative, case-control study demonstrated the real-world effectiveness of the BNT162b2 vaccine (Pfizer–BioNTech) and mRNA-1273 vaccine (Moderna) among healthcare personnel in the US.
People who had an allergic response to the first dose of COVID-19 vaccination or who believe they will have an allergy to vaccination should not let their worries delay getting vaccinated — as most of them can still be fully vaccinated safely, suggest studies presented at ACAAI 2021.
It is rare to achieve successful home noninvasive ventilation (NIV) in real life, reports a recent study. To improve patient-centred outcomes, health-related quality of life (HRQOL) and NIV tolerance must then be assessed.
